Biotech · Private company
Anagram Therapeutics, Inc.
Track this companyFree. Adds Anagram Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials21 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- ANG003 Dose APhase 2 · Exocrine Pancreatic Insufficiency (EPI)ClinicalTrials.gov · fetched Nov 12, 2026
- ANG003 Dose BPhase 2 · Exocrine Pancreatic Insufficiency (EPI)ClinicalTrials.gov · fetched Nov 12, 2026
- CreonPhase 2 · Exocrine Pancreatic Insufficiency (EPI)ClinicalTrials.gov · fetched Nov 12, 2026
- ANG003Phase 1 · Exocrine Pancreatic InsufficiencyClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- Phase 2 Study to Assess the Safety and Efficacy of ANG003PHASE2 · RECRUITING · started Apr 24, 2026ClinicalTrials.gov NCT07450547 · fetched Nov 12, 2026
- Phase 1 Study to Assess Safety and Efficacy of ANG003PHASE1 · COMPLETED · started Aug 25, 2023ClinicalTrials.gov NCT06052293 · fetched Nov 12, 2026